Exploring Outcomes and Strategies in OCD Treatment After the First Trial

<p>In this episode, we delve into the potential outcomes after the first SSRI trial for OCD. With SSRIs being a first-line treatment, understanding response patterns is crucial. What course of action should be taken when patients exhibit significant symptom improvement, partial relief, or no response? Discover when to discontinue, switch, or augment treatment.</p> <p>Faculty: David Osser, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC238" target="_blank" rel="noopener"><strong>Learn more about our memberships here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/algorithm-for-the-pharmacotherapy-of-obsessive-compulsive-disorder-2676?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC238" target="_blank" rel="noopener"><strong>Earn 1.25 CME: Algorithm for the Pharmacotherapy of Obsessive-Compulsive Disorder</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/node-2-potential-outcomes-after-the-first-trial-2676-5275?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC238" target="_blank" rel="noopener"><strong>Node 2: Potential Outcomes After the First Trial</strong></a></li> </ul>